Gabriel Tinoco

23PUBLICATIONS
121CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 28, 2026
Correction: Tinoco et al. Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls. Cancers 2026, 18, 641.

|Jul 20, 2026
TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors.

|May 26, 2026
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.

|Apr 30, 2026
Multiomic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

|Mar 20, 2026
Association between area deprivation index (ADI) and initial treatment among patients with desmoid tumors☆.

Alexandra G Lopez-Aguiar, Menglin Xu, Han Gil Kim

|Feb 27, 2026
Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls.

Gabriel Tinoco, Marium Husain, David Liebner

Pageof 4

Frequent Collaborators

4 joint publications

Cornelia M Ulrich

4 joint publications

Sheetal Hardikar

4 joint publications

Ahmad A Tarhini

4 joint publications

Rebecca D Dodd